Market Research Logo

Estonia Pharmaceuticals and Healthcare Report Q2 2016

Estonia Pharmaceuticals and Healthcare Report Q2 2016

BMI View: We expect growth in Estonia's healthcare expenditure to decelerate over the long term given thecountry's fiscally conservative nature, the limited capacity of the national health insurer to accommodatefurther healthcare spending growth and BMI's outlook for the country's economy over the long term.

Drugmakers can expect to see constrained revenue growth in the country as pricing pressures andrestrictive drug reimbursement are employed by the Estonian health insurance fund to restrict healthcareexpenditure.

Headline Expenditure Projections

Pharmaceuticals: Sales will rise from EUR310mn (USD341mn) in 2015 to EUR328mn (USD351mn) in2016, up 6.0% in local currency terms and down 3.2% in US dollar terms. Forecast stayed flat from lastquarter.

Healthcare: Spending will rise from EUR1.22bn (USD1.34bn) in 2015 to EUR1.29bn (USD1.38bn) in2016, up 5.8% in local currency terms and down 2.9% in US dollar terms. Forecast stayed flat from lastquarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Estonia 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Estonia 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Estonia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Estonia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Estonia 2012-2020)
Prescription Drug Market Forecast
Table: Leading Anatomical Therapeutic Chemical (ATC) Groups By Pharmaceutical Sales, 2004-2010 (%)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Estonia 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Estonia 2012-2020)
Generic Drugs Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Estonia 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Estonia 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Estonia 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Estonia 2014-2020)
Pharmaceuticals Risk/Reward Index
Central And Eastern Europe Risk/Reward Index
Estonia Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Table: Key Health Insurance Indicators, 2007-2011
Table: Expenditure By Reimbursed Prescription Medicinal Products, 2005-2010 (EEK '000)
Market Overview
Healthcare Sector
Table: Healthcare Resources (Estonia 2010-2015)
Table: Healthcare Personnel (Estonia 2010-2015)
Table: Healthcare Activity (Estonia 2010-2015)
Table: HIF Healthcare Expenditure, 2006-2011 (EURmn)
Table: Reimbursement Spending By Key Therapeutic Area, 2010-2011 (EURmn)
Table: Medicinal Products Reimbursed For Insured Patients, 2009-2011 (EURmn)
Research And Development
Table: Members Of EBio, 2011
Clinical Trials
Table: Leading Causes Of Death, 2005-2010
Competitive Landscape
Research-Based Industry
Table: Members Of The Association Of International Pharmaceutical Manufacturers In Estonia
Table: Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Table: Pharmacies And Pharmacy Market Ratios, 2004-2009
Company Profile
Grindeks (incorporating Tallinn Pharmaceutical Plant)
Demographic Forecast
Table: Population Headline Indicators (Estonia 1990-2025)
Table: Key Population Ratios (Estonia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Estonia 1990-2025)
Table: Population By Age Group (Estonia 1990-2025)
Table: Population By Age Group % (Estonia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report